Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0000950144-08-001141
Filing Date
2008-02-19
Accepted
2008-02-15 21:43:23
Documents
4

Document Format Files

Seq Description Document Type Size
1 CUMBERLAND PHARMACEUTICALS INC. g06286m9sv1za.htm S-1/A 1858862
2 EX-23.1 CONSENT OF KPMG LLP g06286m9exv23w1.htm EX-23.1 2745
3 GRAPHIC g06286m9g0628602.gif GRAPHIC 3768
4 GRAPHIC g06286m9g0628610.gif GRAPHIC 337
  Complete submission text file 0000950144-08-001141.txt   1868924
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: S-1/A | Act: 33 | File No.: 333-142535 | Film No.: 08624468
SIC: 2834 Pharmaceutical Preparations